P2RY12 and atrial fibrillation: This subgroup analysis of the RE‐DUAL PCI trial studied potential interactions between sex and treatment with dual therapy with dabigatran and P2Y12 inhibition versus triple therapy with warfarin, P2Y12 inhibition, and aspirin specifically in the setting of patients with AF undergoing PCI.